Stock Research: Fulgent Genetics

Independent stock analysis through peer comparison: Get the 360° View as an objective basis for stock decision-making and explore the detailed ranks.

Fulgent Genetics

NMQ:FLGT US3596641098
36
  • Value
    88
  • Growth
    33
  • Safety
    Safety
    65
  • Combined
    76
  • Sentiment
    16
  • 360° View
    360° View
    36
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

Fulgent Genetics, Inc. is a technology-based company providing laboratory and therapeutic development services. Its main businesses include technical laboratory and testing services, professional interpretation of laboratory results, and developing drug candidates for treating cancers using a novel nanoencapsulation and targeted therapy platform. In the last fiscal year, the company had a market cap of $551 million, profits of $107 million, revenue of $283 million, and 1313 employees.

more
Index
NASDAQ
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 27-Feb-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
88 54 39 52
Growth
33 85 3 79
Safety
Safety
65 88 41 41
Sentiment
16 14 16 67
360° View
360° View
36 28 50 87
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
13 21 22 100
Opinions Change
50 50 50 50
Pro Holdings
n/a 8 1 1
Market Pulse
84 47 56 62
Sentiment
16 14 16 67
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
88 54 39 52
Growth
33 85 3 79
Safety Safety
65 88 41 41
Combined
76 51 6 6
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
78 36 7 15
Price vs. Earnings (P/E)
100 84 84 83
Price vs. Book (P/B)
68 84 84 56
Dividend Yield
1 1 1 1
Value
88 54 39 52
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
66 88 12 1
Profit Growth
28 94 10 86
Capital Growth
10 88 4 96
Stock Returns
59 21 37 69
Growth
33 85 3 79
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
84 85 86 82
Refinancing
93 96 94 78
Liquidity
1 15 100 100
Safety Safety
65 88 41 41

Similar Stocks

Discover high‑ranked alternatives to Fulgent Genetics and broaden your portfolio horizons.

Global Payments

NYQ:GPN
Country: USA
Industry: Other Financial Services
Size: X-Large
Full Stock Analysis

Omnicom

NYQ:OMC
Country: USA
Industry: Advertising
Size: X-Large
Full Stock Analysis

Mosaic

NYQ:MOS
Country: USA
Industry: Fertilizers & Agricultural Chemicals
Size: X-Large
Full Stock Analysis

Labcorp

NYQ:LH
Country: USA
Industry: Health Care Services
Size: X-Large
Full Stock Analysis

Frequently Asked
Questions

The company has high growth and safe financing but is expensive (low Value Rank) and has low market sentiment. This is a warning that the stock may be too expensive. This is for an experienced growth investor willing to risk overpaying, but only after conducting thorough research on future growth potential.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing: